Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (161-170 of 200) with videos related to

Pageof 20
Sort By:
Bone Marrow Transplantation|March 7, 2003
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding studyC Bengala, R Danesi, V Guarneri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patientsG Bocci, R Danesi, A D Di Paolo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2000
Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II studyS Ricci, A Antonuzzo, L Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)C Bengala, I Pazzagli, F Innocenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
Oncology|October 29, 2000
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II studyM Lencioni, A Falcone, G Allegrini, et al.
British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.
European Radiology|September 2, 1998
Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trialR Lencioni, O Goletti, N Armillotta, et al.
Clinical Breast Cancer|March 20, 2002
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patientsA Gennari, S Donati, B Salvadori, et al.
Pageof 20

Showing results (161-170 of 200) with videos related to

Sort By:
Pageof 20
Bone Marrow Transplantation|March 7, 2003
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding studyC Bengala, R Danesi, V Guarneri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patientsG Bocci, R Danesi, A D Di Paolo, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2000
Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II studyS Ricci, A Antonuzzo, L Galli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)C Bengala, I Pazzagli, F Innocenti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.
Tumori|January 16, 1998
A randomized trial of chemotherapy with or without estrogenic recruitment in locally advanced breast cancer. North-West Oncology Group (GONO) Study, ItalyE Baldini, G Gardin, P Giannessi, et al.
Oncology|October 29, 2000
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II studyM Lencioni, A Falcone, G Allegrini, et al.
British Journal of Cancer|June 3, 2004
Multicenter randomized phase III trial of epirubicin plus paclitaxel vs epirubicin followed by paclitaxel in metastatic breast cancer patients: focus on cardiac safetyE Baldini, T Prochilo, B Salvadori, et al.
European Radiology|September 2, 1998
Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trialR Lencioni, O Goletti, N Armillotta, et al.
Clinical Breast Cancer|March 20, 2002
Role of 2-[18F]-fluorodeoxyglucose (FDG) positron emission tomography (PET) in the early assessment of response to chemotherapy in metastatic breast cancer patientsA Gennari, S Donati, B Salvadori, et al.
Pageof 20